Clinical trial
The Safety and Efficacy of L-arginine in Patients With Polycystic Ovary Syndrome
NCT06728644 is registered in ClinicalTrials.gov with Shanghai 10th People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Safety and Efficacy of L-arginine in Patients With Polycystic Ovary Syndrome
- Lead sponsor
- Shanghai 10th People's Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 14, 2024
- Completion date
- July 4, 2025
- Enrollment
- 31 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
gut microbiome, l-arginine, polycystic ovary syndrome